PCVX
Price
$35.78
Change
-$0.00 (-0.00%)
Updated
Jul 10 closing price
Capitalization
4.62B
32 days until earnings call
RLFTY
Price
$3.07
Change
+$0.02 (+0.66%)
Updated
Jul 10 closing price
Capitalization
35.41M
Interact to see
Advertisement

PCVX vs RLFTY

Header iconPCVX vs RLFTY Comparison
Open Charts PCVX vs RLFTYBanner chart's image
Vaxcyte
Price$35.78
Change-$0.00 (-0.00%)
Volume$1.74K
Capitalization4.62B
RELIEF THERAPEUTICS HLDG AG
Price$3.07
Change+$0.02 (+0.66%)
Volume$2.86K
Capitalization35.41M
PCVX vs RLFTY Comparison Chart in %
Loading...
PCVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RLFTY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PCVX vs. RLFTY commentary
Jul 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PCVX is a Buy and RLFTY is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 11, 2025
Stock price -- (PCVX: $36.24 vs. RLFTY: $3.07)
Brand notoriety: PCVX and RLFTY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PCVX: 69% vs. RLFTY: 375%
Market capitalization -- PCVX: $4.62B vs. RLFTY: $35.41M
PCVX [@Biotechnology] is valued at $4.62B. RLFTY’s [@Biotechnology] market capitalization is $35.41M. The market cap for tickers in the [@Biotechnology] industry ranges from $314.48B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PCVX’s FA Score shows that 0 FA rating(s) are green whileRLFTY’s FA Score has 1 green FA rating(s).

  • PCVX’s FA Score: 0 green, 5 red.
  • RLFTY’s FA Score: 1 green, 4 red.
According to our system of comparison, PCVX is a better buy in the long-term than RLFTY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PCVX’s TA Score shows that 6 TA indicator(s) are bullish while RLFTY’s TA Score has 4 bullish TA indicator(s).

  • PCVX’s TA Score: 6 bullish, 3 bearish.
  • RLFTY’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, PCVX is a better buy in the short-term than RLFTY.

Price Growth

PCVX (@Biotechnology) experienced а +8.99% price change this week, while RLFTY (@Biotechnology) price change was +1.99% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +10.19%. For the same industry, the average monthly price growth was +16.32%, and the average quarterly price growth was +20.67%.

Reported Earning Dates

PCVX is expected to report earnings on Nov 10, 2025.

Industries' Descriptions

@Biotechnology (+10.19% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PCVX($4.62B) has a higher market cap than RLFTY($35.4M). RLFTY YTD gains are higher at: -37.347 vs. PCVX (-55.729). RLFTY has higher annual earnings (EBITDA): -48.16M vs. PCVX (-512.62M). PCVX has more cash in the bank: 1.67B vs. RLFTY (10.7M). RLFTY has less debt than PCVX: RLFTY (2.42M) vs PCVX (87.2M). RLFTY has higher revenues than PCVX: RLFTY (8.59M) vs PCVX (0).
PCVXRLFTYPCVX / RLFTY
Capitalization4.62B35.4M13,040%
EBITDA-512.62M-48.16M1,064%
Gain YTD-55.729-37.347149%
P/E RatioN/AN/A-
Revenue08.59M-
Total Cash1.67B10.7M15,626%
Total Debt87.2M2.42M3,608%
TECHNICAL ANALYSIS
Technical Analysis
PCVXRLFTY
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
84%
Momentum
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
48%
MACD
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
38%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
42%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
44%
Advances
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 5 days ago
43%
Declines
ODDS (%)
Bearish Trend 5 days ago
80%
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
76%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
76%
View a ticker or compare two or three
Interact to see
Advertisement
PCVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RLFTY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JICPX16.48N/A
N/A
JHFunds2 Capital Appreciation 1
LSVAX19.24N/A
N/A
Loomis Sayles Small Cap Value Admin
JSVTX15.61N/A
N/A
Janus Henderson Small-Mid Cap Value T
QUAYX73.23N/A
N/A
AB Small Cap Growth Advisor
JUEMX26.52N/A
N/A
JPMorgan US Equity R6

PCVX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PCVX has been loosely correlated with ORKA. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if PCVX jumps, then ORKA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PCVX
1D Price
Change %
PCVX100%
+1.29%
ORKA - PCVX
44%
Loosely correlated
-1.12%
DYN - PCVX
41%
Loosely correlated
-0.90%
DNLI - PCVX
40%
Loosely correlated
+2.33%
TSHA - PCVX
40%
Loosely correlated
+0.39%
STOK - PCVX
39%
Loosely correlated
+0.17%
More

RLFTY and

Correlation & Price change

A.I.dvisor indicates that over the last year, RLFTY has been loosely correlated with RLFTF. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if RLFTY jumps, then RLFTF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RLFTY
1D Price
Change %
RLFTY100%
+0.66%
RLFTF - RLFTY
43%
Loosely correlated
+3.26%
ORKA - RLFTY
23%
Poorly correlated
-1.12%
PCVX - RLFTY
21%
Poorly correlated
+1.29%
HOTH - RLFTY
21%
Poorly correlated
+4.20%
NERV - RLFTY
21%
Poorly correlated
-4.21%
More